Utility of diffusion-weighted MRI in characterization of adrenal lesions
- PMID: 20093571
- DOI: 10.2214/AJR.09.2891
Utility of diffusion-weighted MRI in characterization of adrenal lesions
Abstract
Objective: The purpose of our study was to evaluate the utility of apparent diffusion coefficient (ADC) values for characterizing adrenal lesions and determine if diffusion-weighted imaging (DWI) can distinguish lipid-rich from lipid-poor adenomas.
Materials and methods: We retrospectively evaluated 160 adrenal lesions in 156 patients (96 women and 60 men; mean age, 63 years). ADCs and signal intensity (SI) decrease on chemical shift imaging were measured in adrenal lesions with a wide variety of pathologies. Lipid-rich and lipid-poor adenomas were identified by unenhanced CT. The overall predictive power of ADC, SI decrease, and lesion size were determined by receiver operating characteristic (ROC) analysis. Areas under the ROC curve (AUC) were compared for equivalence using nonparametric methods. Sensitivity, specificity, and positive and negative predictive values were calculated. Correlation coefficients were used to assess ADCs versus percentage SI decrease and ADCs versus CT attenuation.
Results: ADCs of adrenal malignancies (median, 1.67 x 10(-3) mm(2)/s; interquartile range, 1.41-1.84 x 10(-3) mm(2)/s) were not different compared with those of benign lesions (1.61 x 10(-3) mm(2)/s; 1.27-1.96 x 10(-3) mm(2)/s; p > 0.05). Cysts (2.93 x 10(-3) mm(2)/s; 2.70-3.09 x 10(-3) mm(2)/s) showed higher ADCs than the remaining adrenal lesions (p < 0.05). The median ADCs of lipid-rich adenomas did not differ from those of lipid-poor ones (p > 0.05). The CT attenuation had no negative or positive correlation with the ADCs of adrenal adenomas (r = -0.05, p = 0.97).
Conclusion: Unlike lesion size and percentage decrease in SI, the ADCs were not useful in distinguishing benign from malignant adrenal lesions. Lipid-poor adenomas could not be distinguished from lipid-rich adenomas and all other nonfatty lesions of the adrenal gland with DWI.
Similar articles
-
Diffusion-weighted imaging of the renal and adrenal lesions.J Comput Assist Tomogr. 2009 Nov-Dec;33(6):828-33. doi: 10.1097/RCT.0b013e31819f1b83. J Comput Assist Tomogr. 2009. PMID: 19940645
-
A prospective study on the utility of diffusion-weighted and quantitative chemical-shift magnetic resonance imaging in the distinction of adrenal adenomas and metastases.J Comput Assist Tomogr. 2012 Jul-Aug;36(4):367-74. doi: 10.1097/RCT.0b013e3182597613. J Comput Assist Tomogr. 2012. PMID: 22805662
-
Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.J Comput Assist Tomogr. 2010 Jul;34(4):506-12. doi: 10.1097/RCT.0b013e3181da3671. J Comput Assist Tomogr. 2010. PMID: 20657216
-
Pitfalls of adrenal imaging with chemical shift MRI.Clin Radiol. 2014 Nov;69(11):1186-97. doi: 10.1016/j.crad.2014.06.020. Epub 2014 Jul 23. Clin Radiol. 2014. PMID: 25062926 Review.
-
Update on CT and MRI of Adrenal Nodules.AJR Am J Roentgenol. 2017 Jun;208(6):1206-1217. doi: 10.2214/AJR.16.17758. Epub 2017 Feb 22. AJR Am J Roentgenol. 2017. PMID: 28225653 Review.
Cited by
-
Abdominal applications of diffusion-weighted magnetic resonance imaging: Where do we stand.World J Radiol. 2013 Mar 28;5(3):68-80. doi: 10.4329/wjr.v5.i3.68. World J Radiol. 2013. PMID: 23671743 Free PMC article.
-
Radiomics approach based on biphasic CT images well differentiate "early stage" of adrenal metastases from lipid-poor adenomas: A STARD compliant article.Medicine (Baltimore). 2022 Sep 23;101(38):e30856. doi: 10.1097/MD.0000000000030856. Medicine (Baltimore). 2022. PMID: 36197274 Free PMC article.
-
Diffusion-Weighted Imaging in Oncology: An Update.Cancers (Basel). 2020 Jun 8;12(6):1493. doi: 10.3390/cancers12061493. Cancers (Basel). 2020. PMID: 32521645 Free PMC article. Review.
-
Adrenal imaging for adenoma characterization: imaging features, diagnostic accuracies and differential diagnoses.Br J Radiol. 2016 Jun;89(1062):20151018. doi: 10.1259/bjr.20151018. Epub 2016 Mar 2. Br J Radiol. 2016. PMID: 26867466 Free PMC article. Review.
-
Utility of T2-weighted MRI to Differentiate Adrenal Metastases from Lipid-Poor Adrenal Adenomas.Radiol Imaging Cancer. 2020 Oct 30;2(6):e200011. doi: 10.1148/rycan.2020200011. eCollection 2020 Nov. Radiol Imaging Cancer. 2020. PMID: 33778748 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical